Trial Profile

A clinical trial of compassionate use treatment with intravenous BPM31510 in patients with Primary CoQ10 Deficiency (PCQD)

Status: Recruiting

Phase of Trial: Clinical Phase Unknown

Latest Information Update: 28 Jun 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ubidecarenone (Primary)
Indications Cancer
Focus Adverse reactions; Expanded access; Therapeutic Use

Most Recent Events

28 Jun 2025 New trial record
18 Jun 2025 According to BPG Bio media release, the company will present on Friday, June 20, clinical update from ongoing compassionate use treatment with intravenous BPM31510 in patients with Primary CoQ10 Deficiency (PCQD) at the United Mitochondrial Disease Foundation's Mitochondrial Medicine Conference 2025 taking place in St. Louis, MO.
18 Jun 2025 Results presented in a BPG Bio media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com